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Abstract
Purpose: The purpose of this study is to evaluate the dosimetric effect of rotational setup errors on the synchronous bi-lateral
lung cancer plans generated by the intensity modulated proton therapy (IMPT) technique. Methods: The original IMPT plans
were generated in for the left planning target volume (PTV) and right PTV of the left lung and right lung, respectively. Each
plan was generated using two beams (lateral and posterior-anterior) with an isocenter placed at the center of the corresponding
PTV. The IMPT plans were optimized for a total dose of 74 Gy[RBE] prescribed to each PTV with 2 Gy(RBE) per fraction.
Original plans were recalculated by introducing simulated rotational errors. For each PTV, 18 rotational plans (±1⁰, ±2⁰, and
±3⁰) for each of the yaw, roll, and pitch rotations were generated. Results: Rotational errors caused the reduction in the clinical
target volume (CTV) and PTV coverage in new rotational IMPT plans when compared to the original IMPT lung plans. The
CTV D99 was reduced by up to 13.3%, 9.1%, and 5.9% for the yaw (+3⁰), roll (-3⁰), and pitch (+3⁰), respectively. The PTV D95
was reduced by up to 8.7%, 7.3%, and 4.6% for the yaw (+3⁰), roll (-3⁰), and pitch (+3⁰), respectively. The PTV V100 showed
the highest deviation with a reduction of dose coverage by up to 40.1%, 31.8%, and 33.9% for the yaw (-3⁰), roll (-3⁰), and pitch
(+3⁰) respectively. Conclusion: The rotational setup errors with magnitude of ≥2⁰ can produce a significant loss of dose coverage
to the target volume in the IMPT of a synchronous bi-lateral lung cancer. The yaw had the most severe impact on the
dosimetric results when compared to other two rotational errors (roll and pitch).
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Introduction
Proton therapy for the cancer treatment continues to receive
wider attention in the radiation oncology and medical
physics communities.1 The physical properties of protons
such as the finite range and sharp distal off behind the Bragg
peak allow the deposition of most of the dose within the
tumor volume and minimize the doses to the normal tissues
and critical structures.1,2 Several investigators have
investigated the use of proton therapy for various sites such
as the prostate cancer3-4, lung cancer5-8, brain cancer9-10, and
breast cancer11-12. Among different types of cancer, the lung
cancer continues to be the leading killer13, and various
external beam radiation therapy techniques such as proton
therapy, 3-dimensional conformal radiation therapy
(3CDRT), intensity modulated X-ray therapy (IMXT), and
volumetric modulated arc therapy (VMAT) are currently
used for the lung cancer treatment.
Earlier treatment planning studies on the lung cancer
reported the dosimetric advantages of the proton therapy
over the photon therapy (such as 3DCRT, IMXT, etc.).6,14,15,16
The study by Zhang et al.17, however, showed that the IMXT
could provide better dosimetric results than the proton
therapy, which used the passive scattering technology. The
majority of the previous lung cancer studies included a single
lesion, and a very few studies8,18,19,20have investigated the use
of radiotherapy for a synchronous bi-lateral lung cancer. The
occurrence of a synchronous bi-lateral lung cancer is very
rare compared to a single lesion lung cancer. Only two
studies8,19 have reported the use of proton therapy planning
of the synchronous bilateral lung cancer. Rana et al.8 showed
that the proton therapy provides dosimetric advantages over
both the IMXT and VMAT for a synchronous bi-lateral lung
cancer. Shi et al.19 also reported the dosimetric results using
the proton therapy were better than using the IMXT. One of
the differences between these two studies was that Rana et
2 Rana et al.: Rotational setup errors in IMPT bilateral lung cancer International Journal of Cancer Therapy and Oncology
www.ijcto.org
© Rana et al. ISSN 2330-4049
al.8 used the uniform scanning proton therapy (USPT),
whereas Shi et al.19 used the double scattering proton
therapy (DSPT). Although both the studies8,19 showed the
dosimetric benefits of the proton therapy over the photon
therapy, the dosimetric effect of the rotational setup errors
in the proton therapy of the synchronous bi-lateral lung
cancers was not evaluated.
More recently, proton therapy community is showing a great
interest in using the pencil beam scanning (PBS), which is
considered as a more advanced technology compared to both
the USPT and DSPT.2,20 The PBS technique can generate
treatment plans with conformal distal and proximal target
coverage. However, the PBS delivery can be very sensitive to
the motion and setup uncertainties.21 The interplay effect
between the lung tumor motion and scanned pencil beams is
also major concern. The combination of setup errors and
interplay effect could result in the target underdosage or
normal tissue overdosage.21
Although the PBS planning for the lung cancer treatment
has been addressed in the past21, the dosimetric impact of
rotational setup errors on the PBS dose distributions of a
bilateral lung cancer is yet to be investigated, especially for
the intensity modulated proton therapy (IMPT) planning
with multi-field optimization technique (hereafter referred
as IMPT).The IMPT planning is typically done by optimizing
all fields together to produce uniform dose coverage to the
target volume. The study on the dosimetric effect of
rotational setup uncertainties is essential in order to ensure
the acceptable dose coverage during the lung cancer
treatment. The purpose of this study is to evaluate the
dosimetric effect of rotational setup errors on the
synchronous bi-lateral lung cancer plans generated by the
IMPT technique.
Methods and Materials
Patient selection and simulation
The computed tomography (CT) dataset of a synchronous
bi-lateral lung cancer case (tumor motion less than 1 cm)
was selected for this study. The patient has consented to
participation in the Proton Collaborative Group (PCG)
REG001-09, WIRB Protocol # 20091082. The patient had
undergone 4-dimensional (4D) CT simulation in a head first
supine position with the support of immobilization devices
such as wing board, knee roll, and Vac-lok system (CIVCO
Medical Solutions, Kalona, Iowa). The CT images were
acquired with a slice thickness of 1.25 mm using a General
Electric CT Scanner.
Contouring
Since the patient had the synchronous bi-lateral lung cancer,
the radiation oncologist delineated the internal gross tumor
volume (IGTV) in the left and right lungs (left IGTV = 91.69
cc and right IGTV = 35.75 cc). The clinical target volume
(CTV) was generated by a 7 mm uniform expansion around
the IGTV. The planning target volume (PTV) was generated
by a 2.5 mm uniform expansion around the CTV. Normal
lung tissue, heart, esophagus, and spinal cord were contoured
too.
Treatment planning
The CT dataset of a synchronous bi-lateral lung cancer case
was retrieved from the clinical database of our institution,
and imported into the XiO treatment planning system
(version 5.00., CMS Inc, Elekta, St. Louis, MO) for the IMPT
planning. The control IMPT plans were created in the XiO
TPS, which used the beam commissioning data measured on
an IBA Cyclotron (IBA, Louvain-la-Neuve, Belgium). The
average CT dataset (obtained from the 4DCT scan) was used
for proton planning. The left and right IMPT plans were
generated for the left PTV and right PTV, respectively by
using a 2-field (lateral and posterior-anterior) technique as
shown in the Figure 1. Each plan (left and right lung) had its
own isocenter, which was placed at the center of the
corresponding PTV. The IMPT plans (left lung and right
lung) were optimized for a total dose of 74 Gy[RBE]
prescribed to each PTV (left and right) with 2 Gy(RBE) per
fraction. In each plan, the layer spacing was set to 8 mm, and
the proton dose calculations were performed using a pencil
beam algorithm22 with a grid size of 3 mm × 3 mm × 3 mm.
FIG. 1: Beam arrangements in the IMPT planning of a synchronous
bi-lateral lung cancer. Each PTV (left and right lung) has its own
isocenter.
FIG. 2: Simulation of rotational setup errors (yaw, roll, and pitch) by
changing couch angles.
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In order to investigate the rotational setup errors, the
original plans (or control plans) were recalculated by
introducing simulated rotational errors (roll, yaw, and pitch)
but keeping the same treatment parameters as for the
original left and right lung plans. Specifically, 18 rotational
plans for each tumor (±1⁰, ±2⁰, and ±3⁰) for each of the yaw,
roll, and pitch rotations were generated. The yaw, roll, and
pitch rotations were simulated by changing one parameter
(e.g., yaw) and keeping other two parameters (e.g., roll and
pitch) fixed. [Figure 2] The rotational setup errors were
assumed to have occurred for each individual fraction.
The CTV was evaluated for the dose at the 99% of the CTV
(D99). The PTV was evaluated for the dose at the 95% of the
PTV (D95) and the relative volume of the PTV receiving at
least 100% and 95% of the prescription dose (V100 and V95,
respectively). For a comparative purpose, the difference in
various dosimetric parameters between the control (or
original) plan and new simulated plans was calculated. The
difference (D) was calculated as:
( ) ( )( ) 100  (1)
( )
X r X cD r
X c
      
where, X = dosimetric parameter (e.g. CTV D99, PTV V95,
etc.); X (r) = dosimetric result in a new plan with a simulated
rotation (r) (r = ±1⁰, ±2⁰, and ±3⁰ for each of the yaw, roll,
and pitch); and X (c) = dosimetric result in the control (c)
treatment plan.
Results
Figure 3 illustrates the difference (see equation 1) in the
dosimetric result for a given parameter between the
original/control plan and rotational plans for various yaw
(±1⁰, ±2⁰, and ±3⁰), roll (±1⁰, ±2⁰, and ±3⁰), and pitch (±1⁰,
±2⁰, and ±3⁰) rotations.
CTV
The rotational errors resulted CTV coverage loss as the
differences in the CTV D99 were up to -13.3%, -5.6%, and
-5.9% for the yaw (+3⁰), roll (+3⁰), and pitch (-3⁰),
respectively, in the left lung, and up to -10.3%, -9.1%, and
-5.6% for the yaw (-3⁰), roll (-3⁰), and pitch (+3⁰),
respectively, in the right lung.
PTV
For the PTV D95, the differences were up to -8.7%, -4.1%,
and -2.8% for the yaw (+3⁰), roll (+3⁰), and pitch (-3⁰),
respectively, in the left lung, and up to -8.4%, -7.3%, and
-4.6% for the yaw (-3⁰), roll (-3⁰), and pitch (+3⁰),
respectively, in the right lung. For the PTV V95, the
differences were up to -8.0%, -2.9%, and -1.7% for the yaw
(+3⁰), roll (+3⁰), and pitch (-3⁰), respectively, in the left lung,
and up to -10.8%, -9.3%, and -2.9% for the yaw (-3⁰), roll
(-3⁰), and pitch (+3⁰), respectively, in the right lung. The
highest difference was obtained for the PTV V100 as the
differences were up to -23.1%, -14.3%, and -11.1% for the
yaw (+3⁰), roll (+3⁰), and pitch (-3⁰), respectively, in the left
lung, and up to -40.1%, -31.8%, and -33.9% for the yaw
(-3⁰), roll (-3⁰), and pitch (+3⁰), respectively, in the right
lung.
Discussion
In this paper, the dosimetric effect of rotational errors (yaw,
roll, and pitch) on the IMPT planning of the synchronous
bi-lateral lung cancer was investigated. The results from our
study demonstrated that the rotational errors can produce a
significant loss of dose coverage in the IMPT lung cancer
treatment. The yaw had the most severe impact on the
dosimetric results when compared to other two rotational
errors (roll and pitch). For ±3⁰ yaw error, the difference was
found to be more than -10% (up to -13.3% for the CTV D99,
-10.83% for the PTV V95, and -40.1% for the PTV V100).
Even for a smaller degree of rotational setup error, the
dosimetric impact could be significant. For the smallest
degree of rotation (±1⁰) evaluated in this study, the
differences in the CTV D99 were up to -7.63% for the yaw,
up to -3.3% for the roll, and up to -5.6% for the pitch
rotations. These results demonstrate that the loss of dose
coverage to the CTV and PTV could be clinically
unacceptable if the rotational errors are not applied during
the patient treatment setup.
Another interesting observation from this study was that the
differences in the dosimetric results were not consistent
despite the same magnitude of rotation. For example, the
CTV D99 of the left lung had the differences of -3.2% for -3⁰
yaw and -13.3% for +3⁰ yaw. Similar discrepancy was
observed for the right lung as the CTV D99 had the
differences of -10.3% for -3⁰ yaw and -3.6% for +3⁰ yaw. The
PTV D95 of the right lung had the differences of -7.3% and
-0.8% at -3⁰ and +3⁰ roll, respectively. These results suggest
that the difference in the dose coverage may vary even if the
magnitude of the rotational error is the same (e.g., 3⁰ of
yaw). This may be due to the change in range of proton
beam as a result of rotational errors, and proton beams are
sensitive to the changes to the tissue density along the beam
path and tissue inhomogeneities
We evaluated the dose coverage to the CTV and PTV only.
The dosimetric effects of the rotational setup errors on the
OARs were not considered because, the beam entrance
through critical structures was avoided, and the critical
structures were not in the proximity of the target volume.
However, the impact of rotational errors on the OARs may
be essential when the critical structure such as the spinal
cord is abutting the target volume.
Currently, our institution (ProCure Proton Therapy Center
OKC) uses the USPT technique to treat the lung cancer with
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tumor motion less than 1 cm. However, the lung tumor
motion would be even more critical for the PBS. The review
article by Wink et al.20 reported that the MD Anderson
Cancer Center has started using PBS for the treatment of
non-small-cell lung cancer with tumor motion below 5 mm.
The use of PBS for the lung cancer treatment is yet to be
fully explored and need further studies because of the
uncertainties involved between the tumor motion and
scanned pencil beams. For the lung cancer treatment using
the USPT technique, the rotational setup tolerance at our
institution is ±2⁰ for the yaw, roll, and pitch rotations. Based
on the results presented in this article, the rotational setup
tolerance of ±2⁰ may need to be re-evaluated for the lung
cancer treatment using PBS technology.
One of the limitations of our study is the limited number of
bilateral lung cases. Due to unavailability of additional
bi-lateral lung cancer cases in our current database, we were
unable to investigate the impact of rotational errors on the
tumors of different shape and size. The interplay effect was
also not investigated. Future studies need to address the
impact of setup errors and interplay effect on the PBS
planning of highly irregular lung tumors by including a large
cohort of bilateral lung cancer patients.
FIG. 3: Difference between the control plans and new rotational plans for various yaw (±1⁰, ±2⁰, and ±3⁰), roll (±1⁰, ±2⁰, and ±3⁰), and pitch
(±1⁰, ±2⁰, and ±3⁰) rotations. The results are presented for the left lung and right lung plans (synchronous bi-lateral lung cancer case).
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Conclusion
The rotational setup errors with magnitude of ≥2⁰ can
produce a significant loss of dose coverage to the target
volume in the IMPT of a synchronous bi-lateral lung cancer.
The yaw had the most severe impact on the dosimetric
results when compared to other two rotational errors (roll
and pitch).
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